I. Garajova

[Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorithm of patients with rectal carcinoma].

R. Vyzula, P. Fabián, O. Slabý, 2008, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

Significant overexpression of Hsp 110 gene during colorectal cancer progression

J. Michálek, R. Vyzula, R. Nenutil, 2022 .

Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management

F. Gelsomino, I. Garajova, S. de Lorenzo, 2022, Current oncology.

Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer

M. Ferracin, E. Porcellini, G. Brandi, 2017, International journal of molecular sciences.

The treatment of rectal cancer with synchronous liver metastases: A matter of strategy.

F. Gelsomino, A. Spallanzani, I. Garajova, 2019, Critical reviews in oncology/hematology.